Member Info for skid35

What would be great if he buys some shares in the open market. Great cv and looks a great for to where distil are in their development

Letitrun.
I think you are now arguing against yourself. Your comments from "in reality.." Show the benefit of understanding data, both at a summary level but also at a deep dive level by the variables you have outlined.
Board papers I am sure have this level of detail for review.

Tracy, do you believe they are waiting for something to close, rather than be in progress ?

Letitrun.
"Waste of time dividing up deals with revenues", what a ridiculous comment.
As you say some won't deliver revenue (what proportion? Is the fail rate improving? Common denominators for these companies?), As you say many will take some time to revenue (how long? Is it improving ? Difference between an existing customer and new with a new product, what is the ramp afterwards, geographic expansion vs in country).
All companies are built on data with a an attempt to have a detailed understanding of behaviours, this helps understand and change strategy to improve performance and for more accurate forecasting. Any decent CEO will be all over these numbers.

The problem with ENET from an IR comms perspective is that deals are very concentrated and lead times from opportunity initiation to signing / revenue are long and uncertain / out of Andrew direct control - I do have some sympathy here.
I have always thought / hoped they were waiting for real progress before an update, but this has taken longer than expected.
Always a believer in standard timetabled updates, so shareholders know the format of what is coming and when - once a quarter ideal.
As with others I think PIs and other shareholders have been very supportive of the BOD, an update would be welcome.

I think he knows the current trading more than supports the share price in this market.
Takeover talk or action cream on the top.

Very well run and controlled company, results as expected.
Nice note that new products had a small impact and only in q4, really expect these to ramp very quickly for the half year numbers.
Any weakness in the share price I will be adding.

Mike.

Article today in the Sunday Times about a cambridge company roboscientific which has a £5k covid detector, has produced detectors in the past for poultry.
Cannot find any link with kromek, with the exception of both receiving govn funds from the same source and a note on Durham uni.
Any ideas on this one?

Always in the back of my mind about a takeover, a great addition for a cyber company looking to fill out a range of products.

George, always the issue to wonder whether you're buying at a low price before the news, or the price is low because there is no news. Possibly a lack of the larger deals but good deal volume overall, especially with enlarged channel coverage.
As you say any cyber company which is rated by analysts such as Gartner really should be doing well.
Two shares we own, enet and cns, in the doldrums a little and waiting for a few sparks to get them firing.

Any interesting information from any questions at the agm yesterday ?
Getting to half a year with no business wins rns, updates.

Andrew.
Firstly Wikipedia ratings are not worth the paper they are written on.
Much as I understand the KPI of average revenue per deal I don't think this really gives a good indication, much more granularity is required - how many are in the market, how many are producing quarterly revenues within certain bands, how quickly does it take to produce material revenue, what is the trajectory once material revenue starts, how many are dumped (which is not negative and should be expected).
I think you are right that 5 or so deals should be 90% plus of revenue in a few years time. For the time being it would be good to have 50 deals doing a nice 2.5m run rate at the bottom end, with "super" deals and stbx on top of this.
Opti / soh aren't great in providing detailed breakdowns on actuals, preferring to concentrate on interviews on what is / might be round the corner in x years time. The teasing of what might be really does need to turn into top and bottom line execution in the near future.
After a great h1 20 and a very weak h2 20 we really need to see growth is still moving in the right direction.
At the moment the share price reflects the promise of greatness and delivery which is underwhelming compared to the opportunity the company has told us about. I do however think it represents good value, especially compared to where it was a year or two ago.
I think your last line on being patient is spot on, hopefully long term holders will be rewarded with a substantial re rating (2-4 x where it is now) but I'm really haven't a clue on the timing of when this might be.

Sergi,
I think the issue here is not getting investors too excited when both the scale and timing of opportunities are still up in the air at various stages in the pipeline, and at varying levels of commercial / legal secrecy which limits openness.
As someone working in software tech there is always a run rate of deals / renewals which provides a bedrock of business allowing for more certainty and accurate forecasting, and where the time from opportunity origination to contract close is shorter and can be determined by history.
Now the fundraise is out of the way there is no real reason, apart from short term price support, to be too bullish.
I am not sure an open C C is appropriate at this stage in the companies development as it may leave us with more questions and guessing than we started with. What I would like is a timetable quarterly update, so we are not left speculating that no news is bad news.

Important to remember that most of the large holders, including myself, are very much in the money in the late 40s, I expect with gains of 30-50%.
It's always going to drift between news, my average price has been helped by only buying in the periods of news drought.
I have said previously hopefully the real price gains will be at the back end of 22 / early 23 BUT this will be based on news and business development in 21, but not priced in by the market.
I was patient when this was in the teens when I could have lost a great deal of money, I the late forties I am still patient....but would like an update.

A bit brief !
All very positive, but as a lth I have seen this optimism on a regular basis. Anyway hopefully will put a bit of a skip in the share price for get is back in the twenties. no
Always been a little unsure on the customers for the detector and use. I can't see this as an entry/ no entry, open / close type decision maker - more as a replacement for the weekly testing (imperial college?) with the same people to provide another data point. Clearly points of entry (ports, airports, rail terminus) analysis would be great.
Also had the impression other lines of business were performing, hopefully they can manage finances / commercials for no further cash raise and get the p&l motoring.

Actually just thought, the cash number / debtors / creditors would be worth knowing just to follow through cash forecasting this year.

Uhlf, results / stat accounts would have been completed a long while ago. I can't see any arguing over going concern issues with the auditors. They won't really tell us anything anyway.
I think it's really just any forward looking comments from the chairman / CEO in their commentary on the investor focused element of the formal report, or outside of this a more complete update.

Uhlf,
Yes, brokers notes for smaller companies tend to be a little bland.
Hopefully with results we might get a conservative view direct from enet - as usual may need to read between the lines.
Also hope we have no more cash raises, but if we do are open to all shareholders and are to support very unexpected business levels.

As others, thanks for putting this up on a public forum.
120m yearly revenue with the margins opti have, and their low opex, this would throw off profit and cash. Not sure what any similar IS companies have as their PE ratio, but even without sbtx this would get to a very conservative half a billion valuation. Would like to know the expected timescale.
Glad the sbtx dividend and nasdaq listing are in the back ground awaiting the right valuations for shareholder benefit.
Also good to hear 2020 numbers are in the right ballpark, Looking forward to h1 estimates and forward to what H2 brings - not just in absolute numbers but in general business development.

Aquae,
Would love one of the big good manufacturers who completely dominate western food markets (must be said to the massive detriment to people's health) to come on board, along with a lot of other things just isn't priced into the underlying market value of opti (less skin) at even a less than 5% probability.
Like yourself looking forward to update on progress, I hope the h1 19 to h1 20 shows the real growth that can continue rather than h2 19 vs h2 20.